GW0742 — Safety, Research, Risks & Legal Status

Not medical advice. GW0742 is discussed here for informational and harm-reduction purposes only. We do not endorse use, and any dosing context is informational, not a protocol.

Also known as	GW-0742, GW-501516 analog
Category	SARM
parent_compound	Cardarine (GW-501516); abandoned for cancer risk
cancer_signal	Multiple tumor types observed in animal chronic toxicity studies
US legal status	Not FDA-approved for human use. Sold as a research chemical only. WADA-banned. No legitimate pharmaceutical source. Related to banned Cardarine (GW-501516).

What is GW0742?

PPAR-delta agonist related to the banned research compound Cardarine (GW-501516). Synthetic nuclear receptor activator designed to modulate metabolic and muscle physiology. Not a traditional androgen-targeting SARM.

How it works

Activates peroxisome proliferator-activated receptor delta (PPAR-delta), which regulates fatty acid oxidation, glucose homeostasis, and vascular function. Cardarine showed aberrant activation in non-target tissues.

Background & history

GW-501516 (Cardarine) developed by GSK for metabolic and cardiovascular indications in 1990s. Abandoned after cancer signals in animal studies. GW-0742 is unrelated subsequent research; never developed for clinical use.

What the research says

Preclinical and animal studies only. No published human trials. Animal research reports metabolic effects, endurance capacity improvements, and lipid profile changes. GW-501516 (parent compound) was discontinued due to cancer signals in animal studies.

Reported effects

Studied for metabolic and lipid effects in animals
Reported endurance capacity changes in preclinical models
PPAR-delta pathway activation; distinct from androgen mechanism
No human efficacy or safety data
Parent compound (Cardarine) abandoned due to safety signals

Dosing & administration (informational)

Preclinical animal studies used dose protocols to assess metabolic efficiency and endurance-capacity phenotypes. No human dosing explored or established.

This is general research/context information, not medical advice or a recommended protocol.

Safety & side effects

No human safety data; high risk due to parent compound history
Cardarine (GW-501516) showed cancer signals in animal models; similar risk profile unknown
PPAR-delta activation effects on human tissues untested
WADA-banned; sport-prohibited substance
Unverified sourcing and contamination risk extremely high
Abandoned for human development; severe caution warranted

Drug & supplement interactions

PPAR-delta activation may amplify effects of other metabolic compounds
Possible lipid-lowering drug interactions (statins, fibrates)
Unpredictable effects on glucose metabolism and insulin signaling
Unknown tissue-specific off-target activation in humans

Who should avoid it

Absolutely avoid; parent compound abandoned due to cancer signals
In individuals with lipid disorders or cardiovascular disease
Concurrent use with other metabolic or PPAR-targeting agents
In competitive sport (WADA-banned) or any research setting

How it is commonly combined

Extreme risk; combining with other research compounds and a failed predecessor creates unpredictable and dangerous pharmacology.

Legal & regulatory. Not FDA-approved for human use. Sold as a research chemical only. WADA-banned. No legitimate pharmaceutical source. Related to banned Cardarine (GW-501516).

Quality & harm reduction

T
h
i
r
d
-
p
a
r
t
y
C
O
A
m
a
n
d
a
t
o
r
y
;
c
h
e
m
i
c
a
l
i
d
e
n
t
i
t
y
m
u
s
t
b
e
c
o
n
f
i
r
m
e
d
t
o
e
x
c
l
u
d
e
C
a
r
d
a
r
i
n
e
o
r
o
t
h
e
r
c
o
n
t
a
m
i
n
a
n
t
s
.
V
e
r
i
f
y
p
u
r
i
t
y
a
n
d
s
u
p
p
l
i
e
r
t
r
a
n
s
p
a
r
e
n
c
y
.

Lab testing & harm-reduction tools

If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.

Compare testing options

Frequently asked questions

Is GW-0742 safe?

Unknown in humans. Parent compound Cardarine showed cancer signals in animal studies and was abandoned.

Why is Cardarine banned?

Cancer and tumors observed in animal studies. GW-0742 is a related analog with unknown but potentially similar risks.

Has it been tested in people?

No published human trials. This is pure preclinical research.

Why would anyone use it?

Anecdotal reports of metabolic effects, but zero human evidence and a dangerous precursor history.

What is the cancer risk?

Parent compound showed carcinogenicity in animals; GW-0742 tumor risk unknown but structurally related.

References & further reading

WADA Prohibited List (PPAR-delta agonists and analogs)
FDA guidance on discontinued research compounds (Cardarine history)
PubMed preclinical PPAR-delta agonist pharmacology and carcinogenicity signals